RASSF6, or Ras association domain-containing protein 6, is a member of the RASSF family of proteins that function as tumor suppressors and are involved in regulating various cellular processes, including cell proliferation, apoptosis, and cell cycle control. RASSF6 contains a Ras association domain (RA) and a Salvador/RASSF/Hippo (SARAH) domain, which facilitate its interactions with other proteins and are essential for its biological function. Functionally, RASSF6 has been implicated in the regulation of microtubule stability, mitotic spindle assembly, and cell cycle progression, particularly during mitosis. Furthermore, RASSF6 interacts with key signaling proteins, such as Ras and the mitotic kinase Aurora-A, indicating its involvement in critical cellular signaling pathways.
The activation of RASSF6 involves various mechanisms that regulate its function and protein-protein interactions. One such mechanism is post-translational modifications, including phosphorylation and ubiquitination, which can modulate RASSF6's stability, subcellular localization, and interactions with binding partners. Additionally, activation of upstream signaling pathways, such as the Hippo signaling pathway or the Ras/MAPK pathway, can indirectly impact RASSF6 activity by influencing its localization or ability to interact with other proteins. Moreover, changes in the expression levels of RASSF6 or its interacting partners may also contribute to its activation, as alterations in protein abundance can affect RASSF6-mediated signaling cascades. Understanding the intricate mechanisms underlying RASSF6 activation is crucial for elucidating its physiological functions and its role in disease pathogenesis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA energizes Protein Kinase C (PKC), a key player in the RASSF6 pathway. PKC activation initiates a series of signaling events that boost the functional activity of RASSF6, as RASSF6 is directly involved in the PKC-regulated pathways. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin heightens intracellular cAMP levels by stimulating adenylate cyclase. The amplified cAMP levels intensify the cAMP-dependent pathways where RASSF6 operates, leading to its enhanced activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
IBMX sustains high intracellular cAMP levels by inhibiting phosphodiesterases. The enduring cAMP levels boost the cAMP-dependent pathways where RASSF6 is directly implicated, thereby amplifying its activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin lifts intracellular calcium levels, a pivotal event that can enhance the functional activity of RASSF6, given its role in calcium-dependent signaling processes. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases 1 and 2A. Inhibition of these phosphatases can enhance the phosphorylation state of proteins in the pathways where RASSF6 is directly involved, leading to its functional activation. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Y-27632 inhibits Rho-associated protein kinases (ROCK). Inhibition of ROCK can lead to the alteration of signaling events in the pathways where RASSF6 is directly involved, leading to its enhanced activity. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000B sc-24000C | 10 µg 100 µg 500 µg 1 mg | $160.00 $750.00 $1400.00 $3000.00 | 59 | |
Calyculin A is a potent inhibitor of protein phosphatases 1 and 2A. By inhibiting these phosphatases, it can impact the phosphorylation state of proteins in the pathways where RASSF6 is directly involved, leading to its enhanced activity. | ||||||